We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$169M
AUM Growth
-$69.7M
(-29%)
Cap. Flow
-$68M
Cap. Flow
% of AUM
-40.18%
Top 10 Holdings %
Top 10 Hldgs %
42.32%
Holding
107
New
38
Increased
7
Reduced
15
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$5.66M |
| 2 |
Edwards Lifesciences
EW
|
+$3.26M |
| 3 |
SIEN
Sientra, Inc.
SIEN
|
+$3.25M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3M |
| 5 |
Qiagen
QGEN
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$6.09M |
| 2 |
HCA Healthcare
HCA
|
+$3.95M |
| 3 |
Boston Scientific
BSX
|
+$3.87M |
| 4 |
HOLX
Hologic
HOLX
|
+$3.85M |
| 5 |
ATHN
Athenahealth, Inc.
ATHN
|
+$3.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.93% |
| 2 | Industrials | 2.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
United Therapeutics
UTHR
$22.5B
| $2.25M | 1.33% |
20,000
-909
| -4% | -$115K |
|
27
PUT
Rigel Pharmaceuticals
RIGL
$773M
| $2.12M | 1.25% |
+60,000
| New | +$2.4M |
|
|
28
Rigel Pharmaceuticals
RIGL
$773M
| $2.07M | 1.22% |
58,456
-2,000
| -3% | -$80.1K |
|
|
ZGNX
29
DELISTED
Zogenix, Inc.
ZGNX
| $2.01M | 1.19% |
50,268
-80,000
| -61% | -$3.17M |
|
|
ARNA
30
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.98M | 1.17% |
50,000
+22,017
| +79% | +$856K |
|
|
NTUS
31
DELISTED
Natus Medical Inc
NTUS
| $1.94M | 1.15% |
+57,620
| New | +$1.82M |
|
32
CALL
Amgen
AMGN
$224B
| $1.71M | 1.01% |
+10,000
| New | +$1.84M |
|
|
AGN
33
DELISTED
Allergan plc
AGN
| $1.68M | 0.99% |
+10,000
| New | +$1.68M |
|
|
AGN
34
PUT
DELISTED
Allergan plc
AGN
| $1.68M | 0.99% |
+10,000
| New | +$1.68M |
|
35
CALL
Incyte
INCY
$24.5B
| $1.67M | 0.98% |
20,000
| – | – |
|
|
SPPI
36
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.61M | 0.95% |
+100,000
| New | +$1.98M |
|
|
FOLD
37
DELISTED
Amicus Therapeutics
FOLD
| $1.5M | 0.89% |
+100,000
| New | +$1.52M |
|
38
CALL
Accuray
ARAY
$36M
| $1.5M | 0.89% |
+300,000
| New | +$1.57M |
|
|
CSII
39
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.47M | 0.87% |
+67,000
| New | +$1.61M |
|
|
NVTR
40
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $1.47M | 0.87% |
+112,500
| New | +$1.14M |
|
41
Rocket Pharmaceuticals
RCKT
$378M
| $1.34M | 0.79% |
+71,459
| New | +$1.17M |
|
|
42
Incyte
INCY
$24.5B
| $1.25M | 0.74% |
+15,000
| New | +$1.35M |
|
43
Glaukos
GKOS
$10.8B
| $1.23M | 0.73% |
+40,000
| New | +$1.21M |
|
|
CFMS
44
DELISTED
Conformis, Inc. Common Stock
CFMS
| $1.06M | 0.63% |
+29,242
| New | +$1.23M |
|
45
KALA BIO
KALA
$15.1M
| $1.03M | 0.61% |
+26
| New | +$987K |
|
46
Evolus
EOLS
$528M
| $926K | 0.55% |
+102,544
| New | +$1.17M |
|
47
Exelixis
EXEL
$12.8B
| $886K | 0.52% |
40,000
-40,000
| -50% | -$1.11M |
|
|
BHVN
48
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $829K | 0.49% |
32,186
-10,000
| -24% | -$299K |
|
|
AIMT
49
DELISTED
Aimmune Therapeutics
AIMT
| $821K | 0.49% |
+25,782
| New | +$907K |
|
|
ARRY
50
CALL
DELISTED
Array Biopharma Inc
ARRY
| $816K | 0.48% |
+50,000
| New | +$801K |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q1 2018 Portfolio in Review
As of Q1 2018, Pura Vida Investments held 107 positions worth $169M, down 29% from $239M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Pura Vida Investments withdrew a net $68M in Q1 2018, closing 41 positions and reducing 15 holdings. Its most notable exit was Dentsply Sirona, an estimated $6.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 46% a quarter earlier, followed by Industrials.
Against the trend, Pura Vida Investments opened a new position in Merck worth $5.45M.
- Pura Vida Investments's largest Q1 2018 buy was Merck: 104,800 shares worth $5.45M.
- Pura Vida Investments added most to Alexion Pharmaceuticals in Q1 2018, an estimated $3M increase.
- Pura Vida Investments's biggest Q1 2018 reduction was Boston Scientific, cutting an estimated $3.87M.
- Pura Vida Investments fully exited Dentsply Sirona in Q1 2018, selling an estimated $6.09M.
- Pura Vida Investments's ten largest holdings make up 42% of its $169M portfolio in Q1 2018.
- Pura Vida Investments opened 38 new positions and closed 41 in Q1 2018.
- Pura Vida Investments's portfolio value fell 29% quarter-over-quarter to $169M.
Based on Pura Vida Investments's 13F filing for Q1 2018, filed 14 May 2018.